Akèy › Neuropathies sensorielles et autonomes héréditaires › Texas › Houston
Etid klinik pou Neuropathies sensorielles et autonomes héréditaires nan Houston, TX
5 etid pou Neuropathies sensorielles et autonomes héréditaires ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of ACR-2316 in Specific Advanced Solid Tumors
Ap rekriteFaz 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Ap rekriteFaz 2
- Houston Methodist Hospital, Houston
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- University of Texas MD Anderson Cancer Center, Houston
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
Ap rekriteFaz 1
- Research Site, Houston
Etid Neuropathies sensorielles et autonomes héréditaires nan lòt vil
- Arlington, VA7 etid
- San Antonio, TX7 etid
- New York City, NY6 etid
- Boston, MA6 etid
- Nashville, TN6 etid
- Philadelphia, PA5 etid
- Portland, OR4 etid
- Pittsburgh, PA4 etid
- Ann Arbor, MI4 etid
- Washington, DC4 etid
- Aurora, CO3 etid
- Los Angeles, CA3 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.